SLC7A9 and neoplasm: Patients with higher SLC7A9 expression levels in tumour tissues had worse 5-year overall survival outcomes than those with lower SLC7A9 expression levels (p = 0.04, log-rank [Mantel–Cox] test; Fig. 1c).